ATRA vs MTD · rev $128.9M vs P/E 27, rev $3.87B
Atara Biotherapeutics Inc (ATRA) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
ATRA currently screens at market cap $87.1M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the ATRA and MTD stock pages for the full models.
Not investment advice.